Neuroendocrine lung cancer in a patient with limbic encephalopathy due to anti-Hu antibodies: A rare association not to be missed

J Neurol Sci. 2017 Jul 15:378:91-93. doi: 10.1016/j.jns.2017.04.032. Epub 2017 Apr 20.

Authors

A R Pati¹, C Battisti¹, S A Tripodi², A Cerase³, A Vella⁴, L Guidi⁵, A Mignarri¹, M T Dotti⁶, A Federico¹

Affiliations

¹ Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
² Department of Pathology, AOUS, Siena, Italy.
³ Unit of Neuroradiology, Department of Neurosciences, AOUS, Siena, Italy.
⁴ Nuclear Medicine, AOUS, Siena, Italy.
⁵ Unit of Neurology, Hospital of Empoli, Italy.
⁶ Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy. Electronic address: dotti@unisi.it.

PMID: 28566188
DOI: 10.1016/j.jns.2017.04.032

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Autoantibodies / blood*
Brain Diseases / complications
Brain Diseases / diagnostic imaging
Brain Diseases / immunology*
Brain Diseases / therapy
Diagnosis, Differential
ELAV Proteins / immunology*
Humans
Limbic System / diagnostic imaging
Lung Neoplasms / complications*
Lung Neoplasms / diagnostic imaging
Lung Neoplasms / immunology
Lung Neoplasms / therapy
Male
Middle Aged
Neuroendocrine Tumors / complications*
Neuroendocrine Tumors / diagnostic imaging
Neuroendocrine Tumors / immunology
Neuroendocrine Tumors / therapy

Substances

Autoantibodies
ELAV Proteins